" class="no-js "lang="en-US"> Research Archives - Medtech Alert
Friday, March 29, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders

Astellas Pharma and Cullgen have announced a research collaboration and exclusive option agreement to discover […]

Treventis Partners its Preclinical Program in Alzheimer's Disease with Takeda

Treventis Corporation, a privately held biotechnology company, announced today that it has entered an option, […]

Maven Clinic Announces New Clinical Research and Investments in Innovation to Advance Care Model for Women's and Family Health

Maven Clinic, the world’s largest virtual clinic for women’s and family health, has announced several […]

Adrestia Therapeutics Partners with Leading Patient Advocacy Groups to Form Ataxia Telangiectasia Research Consortium

Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, has announced it has […]

Ono Pharmaceutical to Acquire Multiple Research-Stage Oncology Programs Identified with KSQ’s CRISPRomics

KSQ Therapeutics, a clinical-stage biotechnology company developing therapies to treat cancer and autoimmune diseases using […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more